Camurus Annual Report for 2016 released
Lund — 30 March 2017 — Camurus AB (Nasdaq Stockholm: CAMX) today announces that the Annual Report for 2016 now is available at the company’s website: www.camurus.com For more information:Fredrik Tiberg, President & CEO Tel. +46 (0)46 286 46 92fredrik.tiberg@camurus.com Rein Piir, VP Investor RelationsTel. +46 (0)70 853 72 92ir@camurus.com About CamurusCamurus is committed to developing and commercializing innovative and long-acting medicines for the treatment of severe and chronic conditions, including opioid dependence, pain, cancer and endocrine disorders. New